Waldencast (NASDAQ:WALD) Trading Up 5.7%

Waldencast plc (NASDAQ:WALD) shares traded up 5.7% during trading on Monday . The stock traded as high as $5.77 and last traded at $5.77. 1,081 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 68,997 shares. The stock had previously closed at $5.46.

Analysts Set New Price Targets

Separately, Telsey Advisory Group cut their price target on Waldencast from $12.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 22nd.

Waldencast Trading Down 2.9 %

The firm’s 50-day moving average price is $6.62 and its 200 day moving average price is $8.29.

Institutional Investors Weigh In On Waldencast

Several large investors have recently made changes to their positions in the business. Barclays PLC raised its position in Waldencast by 440.0% in the 2nd quarter. Barclays PLC now owns 4,093 shares of the company’s stock worth $31,000 after purchasing an additional 3,335 shares during the period. Amalgamated Bank boosted its holdings in Waldencast by 68.1% during the 3rd quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock valued at $31,000 after acquiring an additional 1,328 shares during the period. Norden Group LLC bought a new position in shares of Waldencast in the first quarter worth approximately $92,000. State Board of Administration of Florida Retirement System bought a new position in shares of Waldencast during the third quarter valued at about $97,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Waldencast during the third quarter worth about $151,000. 41.97% of the stock is owned by hedge funds and other institutional investors.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.